Lucid Diagnostics (LUCD) Accounts Payables (2020 - 2026)

Lucid Diagnostics' Accounts Payables history runs 7 years deep, the most recent figure standing at $1.1 million for Q1 2026.

• Quarterly Accounts Payables rose 29.92% year-over-year to $1.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.1 million (up 29.92% YoY) and the FY2025 annual result came in at $970000.0, down 21.84% from the prior year.
• Accounts Payables was $1.1 million for Q1 2026 at Lucid Diagnostics, up from $970000.0 in the prior quarter.
• Across five years, Accounts Payables topped out at $4.5 million in Q1 2022 and bottomed at $625000.0 in Q1 2023.
• A 5-year average of $1.4 million and a median of $994000.0 in 2023 frame the typical range for Accounts Payables.
• Annual changes were most pronounced in 2022 — Accounts Payables surged 258.34% — and 2023, when it plunged 85.99%.
• Lucid Diagnostics' Accounts Payables stood at $1.1 million in 2022, then soared by 199.53% to $3.2 million in 2023, then slumped by 60.77% to $1.2 million in 2024, then dropped by 21.84% to $970000.0 in 2025, then grew by 11.03% to $1.1 million in 2026.
• Business Quant data shows LUCD's Accounts Payables at $1.1 million in Q1 2026, $970000.0 in Q4 2025, and $751000.0 in Q3 2025.